Exosomes Confer Chemoresistance to Pancreatic Cancer Cells by Promoting ROS Detoxification and miR-155-mediated Suppression of Key Gemcitabine-Metabolising Enzyme, DCK

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2017.18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

JNK Suppression of Chemotherapeutic Agents-Induced ROS Confers Chemoresistance on Pancreatic Cancer Stem Cells

Oncotarget
Oncology
2014English

ST6Gal-I Sialyltransferase Promotes Chemoresistance in Pancreatic Ductal Adenocarcinoma by Abrogating Gemcitabine-Mediated DNA Damage

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Regulation of RAB22A by Mir-193b Inhibits Breast Cancer Growth and Metastasis Mediated by Exosomes

International Journal of Oncology
Cancer ResearchOncology
2018English

Hypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine

Clinical Cancer Research
Cancer ResearchOncology
2004English

HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Exosomes and Tumor-Mediated Immune Suppression

Journal of Clinical Investigation
Medicine
2016English

NT21MP Negatively Regulates Paclitaxel-Resistant Cells by Targeting miR‑155‑3p and miR‑155-5p via the CXCR4 Pathway in Breast Cancer

International Journal of Oncology
Cancer ResearchOncology
2018English

Erratum: The miR-17-92 Cluster Counteracts Quiescence and Chemoresistance in a Distinct Subpopulation of Pancreatic Cancer Stem Cells

Gut
Gastroenterology
2016English

miR-193b Increases the Chemosensitivity of Osteosarcoma Cells by Promoting FEN1-Mediated Autophagy

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy